D
Delphinus Medical Technologies
Delivering medical innovations to transform early detection of breast cancer and save women’s lives all over the world
About Delphinus Medical Technologies
Delphinus Medical Technologies, Inc. is a pioneering company in the medical imaging sector, specializing in advanced breast ultrasound technology. The company has developed a unique 3D whole breast ultrasound system known as SoftVue, which incorporates a circular ultrasound transducer with triple acoustic detection. This technology provides comprehensive imaging by combining reflection imaging for tissue structure and transmission imaging to measure sound speed and attenuation, thereby presenting detailed tissue characteristics.
Delphinus primarily serves healthcare providers, including hospitals and diagnostic imaging centers, aiming to improve breast cancer risk assessment and screening processes. The company operates in the medical imaging market, which is characterized by rapid technological advancements and a growing demand for non-invasive diagnostic tools.
The business model of Delphinus revolves around the sale and leasing of its SoftVue systems, along with providing maintenance and support services. Revenue is generated through direct sales, long-term leasing agreements, and service contracts. The company also engages in collaborative research projects and clinical trials to further validate and enhance its technology, thereby expanding its market reach and credibility.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 21
- Open positions
- None listed
- Dealroom signal
- 63.2/100
- Industry
- Health, Enterprise Software
- Sub-industry
- BioTechnology, Medical Devices, Health Platform
- Sector
- Biotechnology, Oncology, Spinout, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- SaaS
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VCOther financing | Aug 2023 | $12M | — | Trinity Capital | ↗ |
| SERIES DOther financing | Sep 2022 | $30M | $198M | Beringea · Venture Investors Health Fund · North Coast Technology Investors · Hopen Life Science Ventures | ↗ |
Growth signals
Latest recorded traffic for Delphinus Medical Technologies is 3.4K monthly website visits, down 98% over the last three months. Delphinus Medical Technologies's team declined 30% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Delphinus Medical Technologies in the Novi ecosystem
The Delphinus Medical Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Beringea
Arboretum Ventures- NINorth Coast Technology Investors
InvestMichigan
Series B and later4 investors entered at this stage
Venture Investors Health Fund- HVHopen Life Science Ventures
- WVWaycross Ventures
Trinity Capital
Other known investors2 additional known investors
Karmanos Cancer Institute
Wayne State University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Delphinus Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Delphinus Medical Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









